Comparative Clinical Evaluation of Vachadi Gana and Haridradi Gana Kala Basti in Dyslipidemia
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Reduced Levels of Lipid Profile
研究概览
简要总结
Dyslipidemia, characterized by elevated cholesterol, triglycerides, LDL or reduced HDL, is a major risk factor for atherosclerosis. In Ayurveda, it is correlated with Shonita Abhishyanda, a condition arising from Santarpana Nidana such as heavy diet, sedentary lifestyle and incompatible food (Viruddhara) leading to excessive Kapha and Meda in Rasa-Raktavaha Srotas as mentioned in Charaka Samhita, leading to Medoroga. Being Santarpanajanya Vyadhi it requires Apatarpana chikitsa along with srotoshodhana. Basti therapy is considered Ardha Chikitsa has Lekhana, Chedana and Apatarpana properties that helps in reducing pathological meda and correcting agni. Hence Vachadi Gana and Haridradi Gana are indicated in Medoj and Kaphaja Vikara (i.e. Dyslipidemia) in Shodhanadi Gana adhyaya of Ashtanga Hridyam. In the present trial 30 patients will be enrolled who are diagnosed with Dyslipidemia fulfilling the inclusion and exclusion criteria and dividing them into two groups of 15 each. Group A will receive Vachadi Gana Kala Basti and Group B will receive Haridradi Gana Kala Basti each with a single sitting of 16 days. Clinical outcomes and biochemical parameters ( Lipid Profile including Total Cholesterol, Triglycerides, LDL and HLD) will be assessed to evaluate the efficacy of two interventions. This study aims to establish effective Ayurvedic Treatment approaches for the management of Dyslipidemia under the topic "Comparative Clinical Evaluation of Vachadi Gana and Haridradi Gana Kala Basti in Dyslipidemia."
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 30.00 Year(s) 至 55.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients willing for trial with consent.
- •Patients who are fit for Basti.
排除标准
- •Patients having serious ailments like Insulin Dependant Diabetes Mellitus or poorly controlled Diabetes Mellitus, Myocardial Infarction, Cardiac failure, Renal insufficiency, Hypothyroidism, Malignancies, gluco-corticosteroids induced dyslipidaemia.
- •Patients with Secondary Dyslipidemia.
- •Patients unfit for Basti.
- •Patients on statins/any other drug.
- •Pregnant females and lactating mothers.
结局指标
主要结局
Reduced Levels of Lipid Profile
时间窗: 3 WEEKS
次要结局
- Changes in levels of Total Cholesterol, Triglycerides, LDL & HDL(8 WEEKS)
研究者
Kritika Verma
Himalayiya Ayurvedic Pg Medical College And Hospital
